139 related articles for article (PubMed ID: 38160700)
1. Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; van Duin D; Hogan SL; Derebail VK
Am J Kidney Dis; 2024 Jun; 83(6):784-793.e1. PubMed ID: 38160700
[TBL] [Abstract][Full Text] [Related]
2. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis.
Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; Hogan SL; Derebail VK
Nephrol Dial Transplant; 2023 Aug; 38(9):2009-2018. PubMed ID: 36549661
[TBL] [Abstract][Full Text] [Related]
3. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
4. Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease.
Jorgenson MR; Descourouez JL; Singh T; Astor BC; Panzer SE
Pharmacotherapy; 2018 Jan; 38(1):51-57. PubMed ID: 29136299
[TBL] [Abstract][Full Text] [Related]
5. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cytomegalovirus in cardiac transplant recipients receiving induction immunosuppression with antithymocyte globulin.
Jewani PK; Pouch SM; Kissling KT
Clin Transplant; 2018 Nov; 32(11):e13420. PubMed ID: 30290013
[TBL] [Abstract][Full Text] [Related]
7. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
[TBL] [Abstract][Full Text] [Related]
8. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
9. Cause of End-Stage Renal Disease Is Not a Risk Factor for Cytomegalovirus Infection After Kidney Transplant.
Singh T; Peery S; Astor BC; Parajuli S; Djamali A; Panzer SE
Transplant Proc; 2019; 51(6):1810-1815. PubMed ID: 31256873
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
11. Impact of antimetabolite discontinuation following cytomegalovirus or BK polyoma virus infection in kidney transplant recipients.
Dubrawka CA; Progar KJ; January SE; Hagopian JC; Nesselhauf NM; Malone AF
Transpl Infect Dis; 2022 Dec; 24(6):e13931. PubMed ID: 35980197
[TBL] [Abstract][Full Text] [Related]
12. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
Shah AP; Chen JM; Fridell JA
Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498
[TBL] [Abstract][Full Text] [Related]
13. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
14. Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort.
Pullerits K; Garland S; Rengarajan S; Guiver M; Chinnadurai R; Middleton RJ; Chukwu CA; Kalra PA
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366504
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H
Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand.
Chiasakul T; Townamchai N; Jutivorakool K; Chancharoenthana W; Thongprayoon C; Watanatorn S; Avihingsanon Y; Praditpornsilpa K; Srisawat N
Transplant Proc; 2015 Oct; 47(8):2460-4. PubMed ID: 26518951
[TBL] [Abstract][Full Text] [Related]
17. Early clinical manifestations and laboratory findings before and after treatment of cytomegalovirus infection in kidney transplant patients.
Siddiqui WA; Al Salmi I; Jha A; Pakkyara A; Yasir M; Shaheen FAM
Saudi J Kidney Dis Transpl; 2017; 28(4):774-781. PubMed ID: 28748879
[TBL] [Abstract][Full Text] [Related]
18. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
[TBL] [Abstract][Full Text] [Related]
19. The effect of induction therapy on established CMV specific T cell immunity in living donor kidney transplantation.
Stranavova L; Hruba P; Girmanova E; Tycova I; Slavcev A; Fronek J; Slatinska J; Reinke P; Volk HD; Viklicky O
Physiol Res; 2018 May; 67(2):251-260. PubMed ID: 29303612
[TBL] [Abstract][Full Text] [Related]
20. Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation.
Nachbaur D; Larcher C; Kircher B; Eibl G; Nussbaumer W; Gunsilius E; Haun M; Grünewald K; Gastl G
Ann Hematol; 2003 Oct; 82(10):621-7. PubMed ID: 12920570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
